Press Release
ZEISS Strengthens its Presence in the Arab World
New Office in Dubai's Healthcare City
JENA, 26 January 2015 At the opening of the 40th Arab Health, the main exhibition for the healthcare industry in the EMEA (Europe, the Middle East and Africa) region, the Medical Technology business group of ZEISS opened a new office in Dubai Healthcare City (DHCC).
On the occasion of the opening, ZEISS and the branch of the Moorfields Eye Hospital located in Dubai entered into a close partnership in the area of opthalmologists' training for the region. This hospital will also be used as a reference center for ZEISS ophthalmic products in the future. "Over the last number of years, Dubai Healthcare City (DHCC) has become an extremely important location for the healthcare industry which is renowned far beyond Dubai. This is why we deliberately chose the location of the new office right in the DHCC – bringing us closer to the customers of this growth region," says Thomas Simmerer, Member of the Management Board of Carl Zeiss Meditec AG with responsibility for sales, during his welcome speech to invited guests.
Press Contact Jann Gerrit Ohlendorf, Director of Corporate Communications, Carl Zeiss Meditec AG Phone: 03641 220-331, Email: [email protected]
Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG Phone: 03641 220-116, Email: [email protected] www.meditec.zeiss.de/press
Brief profile Carl Zeiss Meditec AG (ISIN: DE0005313704), which Carl Zeiss Meditec headquarters are located in Jena, Germany. The company has subsidiaries in Germany and is listed on TecDax of the German stock exchange, is abroad; more than 50 percent of its employees are based in one of the world’s leading medical technology the USA, Japan, Spain and France. The Center for companies. The company supplies innovative Application and Research in India (CARIn) in Bangalore, technologies and application-oriented solutions designed to India, and the Carl Zeiss Innovation Center for Research and help doctors improve the quality of life of their patients. It Development in Shanghai, China, strengthen the company's provides complete packages of solutions for the diagnosis presence in these fast-growing countries. Around 35 percent and treatment of eye diseases, including implants and of Carl Zeiss Meditec shares are in free float. The remaining consumables. The company creates innovative visualization approx. 65% are held by Carl Zeiss AG, one of the world’s solutions in the field of microsurgery. Carl Zeiss Meditec's leading groups in the optical and optoelectronic industries. medical technology portfolio is rounded off by promising, Carl Zeiss offers innovative solutions for the future-oriented future-oriented technologies such as intraoperative markets of Medical and Research Solutions, Industrial radiotherapy. In fiscal year 2013/14 (ended 30 Solutions, Eye Care and Lifestyle Products. Carl Zeiss AG, September) the company's around 3,000 employees Oberkochen, is fully owned by the Carl Zeiss Foundation. generated revenue of EUR 909 million. Further information at: http://meditec.zeiss.com/
Page 1